Le Lézard
Classified in: Health, Business
Subject: LIC

COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIXtm for Detection of Group A Streptococcus Using CHROMagar's COLOREXtm Media

MURRIETA, Calif., June 14, 2019 /PRNewswire/ -- COPAN and Alverno Laboratories are proud to announce the successful evaluation of the novel COLOREXtm Strep A chromogenic medium using Artificial Intelligence (AI) and digital detection to pre-assess Throat Strep Screens in WASPLabtm.

COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIXtm for Detection of Group A Streptococcus

Alverno Laboratories is the first laboratory in the US to install COPAN's WASPLabtm system, and it continues to lead the pathway in adoption of innovation. "Our vision is to lead and grow through innovative partnerships, cutting edge technology, informatics, and creative people. We are always looking for ways to continuously bring technology or tests to improve patient care and positively impact time to results," stated Dale Kahn, VP of Operations at Alverno Laboratories. The implementation of this new methodology will have a "beneficial impact to our workflow and greatly improve efficiency. We appreciated the support from COPAN during the validation process," added Cindy Keyak MT (ASCP) SSGB, Microbiology Supervisor, Alverno Laboratories, whose team conducted the evaluation and implementation of this exciting new methodology.

Group A Strep (GAS) pharyngitis is an infection caused by Streptococcus pyogenes, responsible for 20% to 30% of sore throats in children between 5 and 15 years old. Transmission occurs by direct contact with a person suffering from Strep A pharyngitis. Crowded spaces increase the risk of spreading the disease, such as schools, childcare facilities, or among family members. The use of antibiotics is recommended to reduce the symptoms and future complications on the patient and to reduce the likelihood of spreading it in the community. Traditional bacteriology culture is the gold standard, when testing for Group A Streptococcus because of its sensitivity compared to rapid antigen testing, and its lower cost compared to molecular testing. CHROMagartm recently developed a new formulation of its COLOREXtm chromogenic media for the detection of Group A Strep to improve and simplify traditional culture methods. Alverno Laboratories recently validated the new COLOREXtm chromogenic media in combination with COPAN's PhenoMATRIXtm for the digital pre-assessing and pre-sorting of throat cultures for GAS.

COPAN's Chromogenic Detection Module (CDM) is part of the PhenoMATRIXtm Suite to accurately detect and differentiate organisms on chromogenic agar for fast pre-assessment. "A very exciting proposal for laboratories that receive a large volume of GAS samples from pharyngeal swabs is to be able to automate and streamline the processing of throat cultures with WASPLabtm and to apply Artificial Intelligence (AI) to this unique chromogenic media with excellent specificity to pre-sort and segregate presumptive positives. 'Never Touch a Negative Plate Again' is not just our motto, it is the core to our development philosophy," stated Norman Sharples, CEO, COPAN Diagnostics, Inc. 

"Introducing our new chromogenic formulation in COLOREXtm Strep A with automation is a powerful example of how it can improve a high throughput test with an easy to read color differentiation of GAS colonies (in orange to red) from bacteria in the complex throat flora. At CHROMagar, we are celebrating our 40th anniversary as the inventors of chromogenic media, and we continue to innovate and develop formulations that facilitate the detection of key clinical pathogens for better patient therapies," concluded Alberto Lerner, President and General Manager, CHROMagar. 

The results of this interesting evaluation will be presented during the 2019 ASM Microbe in San Francisco on Sunday, June 23 as a poster titled "Digital Detection and the use of Artificial Intelligence to Detect Group A Streptococcus using a Chromogenic Agar."

With a reputation for innovation, COPAN is the leading manufacturer of collection and transport systems in the world.  COPAN's collaborative approach to pre-analytics has resulted in Flocked Swabs, ESwabtm, UTMtm Universal Transport Medium, and laboratory automation, WASP® and WASPLabtm.  COPAN carries a range of microbial sampling products, inoculation loops, and pipettes.  For more information, visit www.copanusa.com.



These press releases may also interest you

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biopharmaceutical company which specializes in the development of novel therapies to restore, treat and prevent inner ear diseases such as hearing loss, tinnitus and...

at 00:00
Taipei-based PlexBio Co., Ltd. and Florence-based A. Menarini Diagnostics, announced they have entered into a supply and distribution agreement for PlexBio's IntelliPlextm diagnostic instrument platform and reagent kits for oncology and infectious...

25 jun 2019
ESSA Pharma Inc. ("ESSA" or the "Company") , a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce the results of the votes on matters considered at its annual general meeting of...

25 jun 2019
The Medicines Company (the "Company") today announced the pricing of a public offering of 4,545,455 shares of its common stock at a public offering price of $33.00 per share. Gross proceeds of the offering are expected to be approximately $150...

25 jun 2019
Veterinary Healthcare Market Global Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global veterinary healthcare market.Read the full report:...

25 jun 2019
Amy Almquist of Mechanicsville, PA, discovered at age 31 during a routine OB/GYN appointment that she was experiencing early menopause, also called premature ovarian failure, and was given a 5% chance of conceiving a child on her own. This news...

News published on 14 june 2019 at 17:37 and distributed by: